Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA.

Ling, Xiaodong; Zhang, Luquan; Fang, Chengyuan; Liang, Hao; Zhu, Jinhong; Ma, Jianqun

Ling, Xiaodong; Zhang, Luquan; Fang, Chengyuan; Liang, Hao; Zhu, Jinhong; Ma, Jianqun.

Afiliação

Ling X; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Zhang L; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Fang C; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Liang H; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Zhu J; Department of Clinical Laboratory, Biobank, Harbin Medical University Cancer Hospital, Harbin, China.
Ma J; Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, China.

Transl Lung Cancer Res ; 12(4): 754-769, 2023 Apr 28.

Article em En | MEDLINE | ID: mdl-37197625

Palavras-chave

Lung adenocarcinoma (LUAD); cuproptosis; prognostic signature; tumor immunity; weighted gene co-expression network analysis (WGCNA)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google